Protection by a Fourth Dose of BNT162b2 against Omicron in Israel. Bar-On YM et al.N Engl J Med. 2022 May 5;386(18):1712…

この記事を読む
一臨床医の勉強のための備忘録です。間違いなどあればご指摘を頂ければ幸いです。
この記事を読む
Protection by a Fourth Dose of BNT162b2 against Omicron in Israel. Bar-On YM et al.N Engl J Med. 2022 May 5;386(18):1712…
この記事を読む
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre,…
この記事を読む
Generalizability of immune checkpoint inhibitor trials to real-world patients with advanced non-small cell lung cancer. …
この記事を読む
IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups …
この記事を読む
Continuation of Lorlatinib in ALK-Positive NSCLC Beyond Progressive Disease. Ou SI et al.J Thorac Oncol. 2022 Apr;17(4):…
この記事を読む
Survival after surgery for clinical stage I non-small-cell lung cancer with interstitial pneumonia. Fukui M et al.Lung C…
この記事を読む
Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung C…
この記事を読む
Reducing number of target lesions for RECIST1.1 to predict survivals in patients with advanced non-small-cell lung cance…
この記事を読む
Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19. Hammerman A et al.N Engl J Med. 2022 Feb 16 Epub ahe…
この記事を読む
Survival outcomes of alternate dosing schedule of pemetrexed as maintenance therapy in NSCLC: Single institution experie…